Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Clinical trial NCT01399593 · TERMINATED
Trial details
- NCT number
- NCT01399593
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-02
- Primary completion
- 2014-05-13
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.